188 related articles for article (PubMed ID: 31850756)
1. Identification of Zika Virus NS2B-NS3 Protease Inhibitors by Structure-Based Virtual Screening and Drug Repurposing Approaches.
Santos FRS; Nunes DAF; Lima WG; Davyt D; Santos LL; Taranto AG; M S Ferreira J
J Chem Inf Model; 2020 Feb; 60(2):731-737. PubMed ID: 31850756
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of unlinked NS2B-NS3 protease from Zika virus.
Zhang Z; Li Y; Loh YR; Phoo WW; Hung AW; Kang C; Luo D
Science; 2016 Dec; 354(6319):1597-1600. PubMed ID: 27940580
[TBL] [Abstract][Full Text] [Related]
3. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
Ren J; Lee H; Kotak A; Johnson ME
Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
[TBL] [Abstract][Full Text] [Related]
4. Binding recognition of substrates in NS2B/NS3 serine protease of Zika virus revealed by molecular dynamics simulations.
Nutho B; Rungrotmongkol T
J Mol Graph Model; 2019 Nov; 92():227-235. PubMed ID: 31401441
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
[TBL] [Abstract][Full Text] [Related]
7. Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors.
Lima CS; Mottin M; de Assis LR; Mesquita NCMR; Sousa BKP; Coimbra LD; Santos KB; Zorn KM; Guido RVC; Ekins S; Marques RE; Proença-Modena JL; Oliva G; Andrade CH; Regasini LO
Bioorg Chem; 2021 Apr; 109():104719. PubMed ID: 33636437
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of the linked NS2B-NS3 protease of Zika virus.
Li Y; Phoo WW; Loh YR; Zhang Z; Ng EY; Wang W; Keller TH; Luo D; Kang C
FEBS Lett; 2017 Aug; 591(15):2338-2347. PubMed ID: 28675775
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.
Chong Teoh T; J Al-Harbi S; Abdulrahman AY; Rothan HA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299596
[TBL] [Abstract][Full Text] [Related]
10. Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor.
Chan JF; Chik KK; Yuan S; Yip CC; Zhu Z; Tee KM; Tsang JO; Chan CC; Poon VK; Lu G; Zhang AJ; Lai KK; Chan KH; Kao RY; Yuen KY
Antiviral Res; 2017 May; 141():29-37. PubMed ID: 28185815
[TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
12. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
[TBL] [Abstract][Full Text] [Related]
13. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
[TBL] [Abstract][Full Text] [Related]
14. The Structure of the Zika Virus Protease, NS2B/NS3
Hilgenfeld R; Lei J; Zhang L
Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
[TBL] [Abstract][Full Text] [Related]
15. Extended substrate specificity and first potent irreversible inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease.
Rut W; Zhang L; Kasperkiewicz P; Poreba M; Hilgenfeld R; Drąg M
Antiviral Res; 2017 Mar; 139():88-94. PubMed ID: 28034744
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the Zika virus protease NS2B-NS3.
Voss S; Nitsche C
Bioorg Med Chem Lett; 2020 Mar; 30(5):126965. PubMed ID: 31980339
[TBL] [Abstract][Full Text] [Related]
17. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
18. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.
Shin HJ; Kim MH; Lee JY; Hwang I; Yoon GY; Kim HS; Kwon YC; Ahn DG; Kim KD; Kim BT; Kim SJ; Kim C
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33800763
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
Majerová T; Novotný P; Krýsová E; Konvalinka J
Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
